{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T07:12:50Z","timestamp":1791443570298,"version":"4.3.3"},"reference-count":196,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>The evolving tumor microenvironment (TME) plays a critical role in breast cancer tumorigenesis, growth, and metastatic potential. This study focuses on two key components of the TME: tumor-associated neutrophils (TANs) and the desmoplastic reaction (DR). We will analyze their multifaceted functions, emphasizing the significant mutual relationships among them, which dramatically affect disease outcomes and the effectiveness of treatments. TANs can either suppress or promote tumors, demonstrating notable functional flexibility in response to signals from their immediate environment. Concurrently, the proliferation of myofibroblasts and the extensive deposition of extracellular matrix (ECM), which characterize the DR, substantially alter the tumor\u2019s physical properties, increasing its stiffness. This increased stiffness significantly obstructs immune system cells from accessing the tumor, ultimately limiting the effectiveness of therapies and contributing to a more clinically aggressive tumor behavior. A comprehensive understanding of the interactions among TANs, the desmoplastic stroma, and other elements of the TME is critical for developing new predictive biomarkers and establishing more effective targeted therapies.<\/jats:p>","DOI":"10.3390\/cancers18030404","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T15:41:56Z","timestamp":1769528516000},"page":"404","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Tumor-Associated Neutrophils and Desmoplastic Reaction in the Breast Cancer Tumor Microenvironment: A Comprehensive Review"],"prefix":"10.3390","volume":"18","author":[{"given":"Stavroula","family":"Papadopoulou","sequence":"first","affiliation":[{"name":"Department of Midwifery, School of Healthcare Sciences, University of Western Macedonia, Keptse, 50200 Ptolemaida, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7097-2927","authenticated-orcid":false,"given":"Vasiliki","family":"Michou","sequence":"additional","affiliation":[{"name":"Department of Midwifery, School of Healthcare Sciences, University of Western Macedonia, Keptse, 50200 Ptolemaida, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arsenios","family":"Tsiotsias","sequence":"additional","affiliation":[{"name":"Department of Midwifery, School of Healthcare Sciences, University of Western Macedonia, Keptse, 50200 Ptolemaida, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6051-0860","authenticated-orcid":false,"given":"Maria","family":"Tzitiridou-Chatzopoulou","sequence":"additional","affiliation":[{"name":"Department of Midwifery, School of Healthcare Sciences, University of Western Macedonia, Keptse, 50200 Ptolemaida, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Eskitzis","sequence":"additional","affiliation":[{"name":"Department of Midwifery, School of Healthcare Sciences, University of Western Macedonia, Keptse, 50200 Ptolemaida, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,1,27]]},"reference":[{"key":"ref_1","unstructured":"(2026, January 08). International Agency for Research on Cancer\u2014World Health Organization Cancer Today: Incidence of Breast Cancer in Females in Europe. Available online: https:\/\/gco.iarc.fr\/today\/en\/dataviz\/pie?mode=population&group_populations=0&cancers=20&sexes=2&populations=100_112_191_196_203_208_233_246_250_276_300_348_352_372_380_40_428_440_442_470_498_499_528_56_578_616_620_642_643_688_70_703_705_724_752_756_8_804_807_826."},{"key":"ref_2","first-page":"394","article-title":"Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"ref_3","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_4","unstructured":"World Health Organization (2025, October 23). Breast Cancer. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/breast-cancer."},{"key":"ref_5","first-page":"409","article-title":"Cancer Treatment and Survivorship Statistics, 2022","volume":"72","author":"Miller","year":"2022","journal-title":"CA Cancer J. Clin."},{"key":"ref_6","unstructured":"(2024). Global Cancer Burden Growing amidst Mounting Need for Services. Saudi Med. J., 45, 326\u2013327."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e36905","DOI":"10.1097\/MD.0000000000036905","article-title":"Breast cancer: A review of risk factors and diagnosis","volume":"103","author":"Obeagu","year":"2024","journal-title":"Medicine"},{"key":"ref_8","first-page":"79","article-title":"Anatomy and Physiology of the Breast","volume":"40","author":"Bazira","year":"2022","journal-title":"Surgery"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1093\/jnci\/djae208","article-title":"Genetic Risk, Health-Associated Lifestyle, and Risk of Early-Onset Total Cancer and Breast Cancer","volume":"117","author":"Zhang","year":"2025","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/MOL.0000000000000759","article-title":"Polygenic Risk Scores: How Much Do They Add?","volume":"32","author":"Christoffersen","year":"2021","journal-title":"Curr. Opin. Lipidol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1093\/ije\/dyx242","article-title":"Joint Associations of a Polygenic Risk Score and Environmental Risk Factors for Breast Cancer in the Breast Cancer Association Consortium","volume":"47","author":"Rudolph","year":"2018","journal-title":"Int. J. Epidemiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"djv036","DOI":"10.1093\/jnci\/djv036","article-title":"Prediction of Breast Cancer Risk Based on Profiling with Common Genetic Variants","volume":"107","author":"Mavaddat","year":"2015","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1136\/jmedgenet-2016-104125","article-title":"The Impact of a Panel of 18 SNPs on Breast Cancer Risk in Women Attending a UK Familial Screening Clinic: A Case\u2013Control Study","volume":"54","author":"Evans","year":"2017","journal-title":"J. Med. Genet."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s13058-016-0759-4","article-title":"The Genetics of Breast Cancer Risk in the Post-Genome Era: Thoughts on Study Design to Move Past BRCA and towards Clinical Relevance","volume":"18","author":"Skol","year":"2016","journal-title":"Breast Cancer Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.breast.2023.01.003","article-title":"Polygenic Risk Scores and Breast Cancer Risk Prediction","volume":"67","author":"Roberts","year":"2023","journal-title":"Breast"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/s41523-025-00820-0","article-title":"Polygenic Risk Score for Breast Cancer Risk Prediction in Asian BRCA1 and BRCA2 Pathogenic Variants Carriers","volume":"11","author":"Tai","year":"2025","journal-title":"npj Breast Cancer"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"a026187","DOI":"10.1101\/cshperspect.a026187","article-title":"Inherited TP53 Mutations and the Li\u2013Fraumeni Syndrome","volume":"7","author":"Guha","year":"2017","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/his.14808","article-title":"Hereditary Breast Cancer: Syndromes, Tumour Pathology and Molecular Testing","volume":"82","author":"Sokolova","year":"2023","journal-title":"Histopathology"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"4053","DOI":"10.1158\/1078-0432.CCR-08-0098","article-title":"Mutations in the Nijmegen Breakage Syndrome Gene in Medulloblastomas","volume":"14","author":"Huang","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ajhg.2018.11.002","article-title":"Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes","volume":"104","author":"Mavaddat","year":"2019","journal-title":"Am. J. Hum. Genet."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Akinsipe, T., Mohamedelhassan, R., Akinpelu, A., Pondugula, S.R., Mistriotis, P., Avila, L.A., and Suryawanshi, A. (2024). Cellular Interactions in Tumor Microenvironment during Breast Cancer Progression: New Frontiers and Implications for Novel Therapeutics. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1302587"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Rafaeva, M., Jensen, A.R.D., Horton, E.R., Zornhagen, K.W., Str\u00f8bech, J.E., Fleischhauer, L., Mayorca-Guiliani, A.E., Nielsen, S.R., Gr\u00f8nseth, D.S., and Ku\u015b, F. (2023). Fibroblast-Derived Matrix Models Desmoplastic Properties and Forms a Prognostic Signature in Cancer Progression. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1154528"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s00262-025-04049-5","article-title":"Unraveling the Complex Role of Tumor-Associated Neutrophils within Solid Tumors","volume":"74","author":"Wang","year":"2025","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3892\/ijo.2025.5734","article-title":"Tumor-associated Neutrophils: Critical Regulators in Cancer Progression and Therapeutic Resistance (Review)","volume":"66","author":"Hou","year":"2025","journal-title":"Int. J. Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Moura, T., Laranjeira, P., Caramelo, O., Gil, A.M., and Paiva, A. (2025). Breast Cancer and Tumor Microenvironment: The Crucial Role of Immune Cells. Curr. Oncol., 32.","DOI":"10.3390\/curroncol32030143"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Li, J.J., Tsang, J.Y., and Tse, G.M. (2021). Tumor Microenvironment in Breast Cancer\u2014Updates on Therapeutic Implications and Pathologic Assessment. Cancers, 13.","DOI":"10.3390\/cancers13164233"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Dom\u00ednguez-Cejudo, M.A., Gil-Torralvo, A., Cejuela, M., Molina-Pinelo, S., and Salvador Bofill, J. (2023). Targeting the Tumor Microenvironment in Breast Cancer: Prognostic and Predictive Significance and Therapeutic Opportunities. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms242316771"},{"key":"ref_28","first-page":"170","article-title":"Investigation of the Relationship between Tumor Microenvironment and Prognostic Parameters in Invasive Breast Carcinomas of No Special Type: A Retrospective Analysis","volume":"40","author":"Ozsen","year":"2024","journal-title":"Turk. J. Pathol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/nm.3394","article-title":"Microenvironmental Regulation of Tumor Progression and Metastasis","volume":"19","author":"Quail","year":"2013","journal-title":"Nat. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.1038\/onc.2013.387","article-title":"Tumor Resident Mesenchymal Stromal Cells Endow Na\u00efve Stromal Cells with Tumor-Promoting Properties","volume":"33","author":"Ren","year":"2014","journal-title":"Oncogene"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Salemme, V., Centonze, G., Cavallo, F., Defilippi, P., and Conti, L. (2021). The Crosstalk Between Tumor Cells and the Immune Microenvironment in Breast Cancer: Implications for Immunotherapy. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.610303"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"EMBJ2019104063","DOI":"10.15252\/embj.2019104063","article-title":"Stromal Cell Diversity Associated with Immune Evasion in Human Triple-negative Breast Cancer","volume":"39","author":"Wu","year":"2020","journal-title":"EMBO J."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Tsai, C.-Y., Hsieh, S.-C., Liu, C.-W., Lu, C.-S., Wu, C.-H., Liao, H.-T., Chen, M.-H., Li, K.-J., Shen, C.-Y., and Kuo, Y.-M. (2021). Cross-Talk among Polymorphonuclear Neutrophils, Immune, and Non-Immune Cells via Released Cytokines, Granule Proteins, Microvesicles, and Neutrophil Extracellular Trap Formation: A Novel Concept of Biology and Pathobiology for Neutrophils. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22063119"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Mukaida, N., Sasaki, S., and Baba, T. (2020). Two-Faced Roles of Tumor-Associated Neutrophils in Cancer Development and Progression. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21103457"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"5339","DOI":"10.1038\/s41598-024-55513-8","article-title":"A Novel Tumor-Associated Neutrophil Gene Signature for Predicting Prognosis, Tumor Immune Microenvironment, and Therapeutic Response in Breast Cancer","volume":"14","author":"Zhang","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s13045-021-01187-y","article-title":"Neutrophils in Cancer Carcinogenesis and Metastasis","volume":"14","author":"Xiong","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"51","DOI":"10.62347\/JQDQ1527","article-title":"Prognostic Impact of Tumor-Associated Neutrophils in Breast Cancer","volume":"17","author":"Kakumoto","year":"2024","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00428-021-03141-2","article-title":"Grading of Invasive Breast Carcinoma: The Way Forward","volume":"480","author":"Ellis","year":"2022","journal-title":"Virchows Arch."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s12282-024-01661-8","article-title":"Prognostic Impact of Tumor-associated Stroma in Triple-Negative Breast Cancer","volume":"32","author":"Kakumoto","year":"2025","journal-title":"Breast Cancer"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Li, K., Gong, L., Zhang, Y., Yang, L., Xu, D., Wang, M., and Hu, Y. (2025). Identification of Tumor Associated Neutrophils-Related Genes in Triple-Negative Breast Cancer for Predicting Prognosis and Therapeutic Response through Integrated Single-Cell Analysis. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1613529"},{"key":"ref_41","first-page":"2689","article-title":"Tumor-Associated Neutrophils in Breast Cancer Subtypes","volume":"18","year":"2017","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1158\/1078-0432.CCR-18-2544","article-title":"Tumor-Contacted Neutrophils Promote Metastasis by a CD90-TIMP-1 Juxtacrine\u2013Paracrine Loop","volume":"25","author":"Wang","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"4429","DOI":"10.1158\/1078-0432.CCR-06-3045","article-title":"Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence","volume":"13","author":"Dent","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s10549-011-1554-7","article-title":"Tumor-Infiltrating Lymphocytes Are Correlated with Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer","volume":"132","author":"Ono","year":"2012","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1200\/JCO.2007.14.4147","article-title":"Response to Neoadjuvant Therapy and Long-Term Survival in Patients with Triple-Negative Breast Cancer","volume":"26","author":"Liedtke","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ccr.2009.06.017","article-title":"Polarization of Tumor-Associated Neutrophil Phenotype by TGF-\u03b2: \u201cN1\u201d versus \u201cN2\u201d TAN","volume":"16","author":"Fridlender","year":"2009","journal-title":"Cancer Cell"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/s41571-019-0222-4","article-title":"Tumour-Associated Neutrophils in Patients with Cancer","volume":"16","author":"Shaul","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/sctm.18-0255","article-title":"Neutrophils Derived from Genetically Modified Human Induced Pluripotent Stem Cells Circulate and Phagocytose Bacteria In Vivo","volume":"8","author":"Trump","year":"2019","journal-title":"Stem Cells Transl. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.1097\/MS9.0000000000003251","article-title":"Inflammatory Signaling Pathways in Neutrophils: Implications for Breast Cancer Therapy","volume":"87","author":"Obeagu","year":"2025","journal-title":"Ann. Med. Surg."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"7156","DOI":"10.1097\/MS9.0000000000002679","article-title":"From Inflammation to Invasion: Neutrophils in Cervical Cancer Pathogenesis","volume":"87","author":"Obeagu","year":"2025","journal-title":"Ann. Med. Surg."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"5762","DOI":"10.1097\/MS9.0000000000003609","article-title":"N1 and N2 Neutrophil Subtypes in Breast Cancer: Functional Implications and Clinical Perspectives: A Narrative Review","volume":"87","author":"Obeagu","year":"2025","journal-title":"Ann. Med. Surg."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"4231","DOI":"10.1111\/odi.14863","article-title":"ALDH3A1 Upregulation Inhibits Neutrophils N2 Polarization and Halts Oral Cancer Growth","volume":"30","author":"He","year":"2024","journal-title":"Oral Dis."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Schmidt, E., Distel, L., Erber, R., B\u00fcttner-Herold, M., Rosahl, M.-C., Ott, O.J., Strnad, V., Hack, C.C., Hartmann, A., and Hecht, M. (2024). Tumor-Associated Neutrophils Are a Negative Prognostic Factor in Early Luminal Breast Cancers Lacking Immunosuppressive Macrophage Recruitment. Cancers, 16.","DOI":"10.21203\/rs.3.rs-4012034\/v1"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Wahnou, H., El Kebbaj, R., Hba, S., Ouadghiri, Z., El Faqer, O., Pinon, A., Liagre, B., Limami, Y., and Duval, R.E. (2025). Neutrophils and Neutrophil-Based Drug Delivery Systems in Anti-Cancer Therapy. Cancers, 17.","DOI":"10.3390\/cancers17071232"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.cell.2024.02.005","article-title":"Neutrophil Profiling Illuminates Anti-Tumor Antigen-Presenting Potency","volume":"187","author":"Wu","year":"2024","journal-title":"Cell"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"e005798","DOI":"10.1136\/jitc-2022-005798","article-title":"Prognostic Value of Tumor-Associated N1\/N2 Neutrophil Plasticity in Patients Following Radical Resection of Pancreas Ductal Adenocarcinoma","volume":"10","author":"Chen","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1158\/0008-5472.CAN-23-2135","article-title":"Human Tumor\u2013Associated Macrophages and Neutrophils Regulate Antitumor Antibody Efficacy through Lethal and Sublethal Trogocytosis","volume":"84","author":"Singhal","year":"2024","journal-title":"Cancer Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"e001946","DOI":"10.1136\/jitc-2020-001946","article-title":"Tumor-Associated Neutrophils and Macrophages Interaction Contributes to Intrahepatic Cholangiocarcinoma Progression by Activating STAT3","volume":"9","author":"Zhou","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Rosales, C. (2018). Neutrophil: A Cell with Many Roles in Inflammation or Several Cell Types?. Front. Physiol., 9.","DOI":"10.3389\/fphys.2018.00113"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.7150\/jca.94669","article-title":"Neutrophil Extracellular Traps in Breast Cancer: Roles in Metastasis and Beyond","volume":"15","author":"Xu","year":"2024","journal-title":"J. Cancer"},{"key":"ref_61","first-page":"1178","article-title":"NETosis: Molecular Mechanisms, Role in Physiology and Pathology","volume":"85","author":"Vorobjeva","year":"2020","journal-title":"Biochemistry"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1146\/annurev-cellbio-020520-111016","article-title":"Cellular Mechanisms of NETosis","volume":"36","author":"Thiam","year":"2020","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Jaboury, S., Wang, K., O\u2019Sullivan, K.M., Ooi, J.D., and Ho, G.Y. (2023). NETosis as an Oncologic Therapeutic Target: A Mini Review. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1170603"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"5265","DOI":"10.2147\/IJN.S418259","article-title":"Role and Therapeutic Targeting Strategies of Neutrophil Extracellular Traps in Inflammation","volume":"18","author":"Li","year":"2023","journal-title":"Int. J. Nanomed."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"e162","DOI":"10.1002\/mco2.162","article-title":"Molecular Mechanisms and Therapeutic Target of NETosis in Diseases","volume":"3","author":"Huang","year":"2022","journal-title":"MedComm"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"a037028","DOI":"10.1101\/cshperspect.a037028","article-title":"Neutrophil Extracellular Traps in Host Defense","volume":"12","author":"Burgener","year":"2020","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/jlb.59.2.229","article-title":"Rapid Killing of Human Neutrophils by the Potent Activator Phorbol 12-Myristate 13-Acetate (PMA) Accompanied by Changes Different from Typical Apoptosis or Necrosis","volume":"59","author":"Takei","year":"1996","journal-title":"J. Leukoc. Biol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nm.4294","article-title":"An Emerging Role for Neutrophil Extracellular Traps in Noninfectious Disease","volume":"23","author":"Jorch","year":"2017","journal-title":"Nat. Med."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1083\/jcb.201006052","article-title":"Neutrophil Elastase and Myeloperoxidase Regulate the Formation of Neutrophil Extracellular Traps","volume":"191","author":"Papayannopoulos","year":"2010","journal-title":"J. Cell Biol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1038\/nm.2847","article-title":"Infection-Induced NETosis Is a Dynamic Process Involving Neutrophil Multitasking in Vivo","volume":"18","author":"Yipp","year":"2012","journal-title":"Nat. Med."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1182\/blood-2013-04-457671","article-title":"NETosis: How Vital Is It?","volume":"122","author":"Yipp","year":"2013","journal-title":"Blood"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"7413","DOI":"10.4049\/jimmunol.1000675","article-title":"A Novel Mechanism of Rapid Nuclear Neutrophil Extracellular Trap Formation in Response to Staphylococcus Aureus","volume":"185","author":"Pilsczek","year":"2010","journal-title":"J. Immunol."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Leshner, M., Wang, S., Lewis, C., Zheng, H., Chen, X.A., Santy, L., and Wang, Y. (2012). PAD4 Mediated Histone Hypercitrullination Induces Heterochromatin Decondensation and Chromatin Unfolding to Form Neutrophil Extracellular Trap-like Structures. Front. Immunol., 3.","DOI":"10.3389\/fimmu.2012.00307"},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Martins-Cardoso, K., Almeida, V.H., Bagri, K.M., Rossi, M.I.D., Mermelstein, C.S., K\u00f6nig, S., and Monteiro, R.Q. (2020). Neutrophil Extracellular Traps (NETs) Promote Pro-Metastatic Phenotype in Human Breast Cancer Cells through Epithelial\u2013Mesenchymal Transition. Cancers, 12.","DOI":"10.3390\/cancers12061542"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"4618","DOI":"10.1158\/0008-5472.CAN-21-0836","article-title":"Genetic Risk for Overall Cancer and the Benefit of Adherence to a Healthy Lifestyle","volume":"81","author":"Zhu","year":"2021","journal-title":"Cancer Res."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"3446","DOI":"10.1172\/JCI67484","article-title":"Neutrophil Extracellular Traps Sequester Circulating Tumor Cells and Promote Metastasis","volume":"123","author":"Spicer","year":"2013","journal-title":"J. Clin. Investig."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Martins-Cardoso, K., Ma\u00e7ao, A., Souza, J.L., Silva, A.G., K\u00f6nig, S., Martins-Gon\u00e7alves, R., Hottz, E.D., Rondon, A.M.R., Versteeg, H.H., and Bozza, P.T. (2023). TF\/PAR2 Signaling Axis Supports the Protumor Effect of Neutrophil Extracellular Traps (NETs) on Human Breast Cancer Cells. Cancers, 16.","DOI":"10.3390\/cancers16010005"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"11089","DOI":"10.1158\/0008-5472.CAN-06-2407","article-title":"Preparing the \u201cSoil\u201d: The Premetastatic Niche","volume":"66","author":"Kaplan","year":"2006","journal-title":"Cancer Res."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"4227","DOI":"10.1126\/science.aao4227","article-title":"Neutrophil Extracellular Traps Produced during Inflammation Awaken Dormant Cancer Cells in Mice","volume":"361","author":"Albrengues","year":"2018","journal-title":"Science"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/ncb2767","article-title":"The Perivascular Niche Regulates Breast Tumour Dormancy","volume":"15","author":"Ghajar","year":"2013","journal-title":"Nat. Cell Biol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.immuni.2018.11.009","article-title":"Mets and NETs: The Awakening Force","volume":"49","author":"Balkwill","year":"2018","journal-title":"Immunity"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.ccell.2020.12.012","article-title":"Cathepsin C Promotes Breast Cancer Lung Metastasis by Modulating Neutrophil Infiltration and Neutrophil Extracellular Trap Formation","volume":"39","author":"Xiao","year":"2021","journal-title":"Cancer Cell"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"e70368","DOI":"10.1002\/ctm2.70368","article-title":"Neutrophil Extracellular Traps in Cancer: From Mechanisms to Treatments","volume":"15","author":"Wang","year":"2025","journal-title":"Clin. Transl. Med."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"7590","DOI":"10.1111\/jcmm.15394","article-title":"Kaempferol Blocks Neutrophil Extracellular Traps Formation and Reduces Tumour Metastasis by Inhibiting ROS-PAD4 Pathway","volume":"24","author":"Zeng","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"3556","DOI":"10.1038\/onc.2014.284","article-title":"The Serine Protease Inhibitor Elafin Maintains Normal Growth Control by Opposing the Mitogenic Effects of Neutrophil Elastase","volume":"34","author":"Caruso","year":"2015","journal-title":"Oncogene"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13058-019-1243-8","article-title":"A Window-of-Opportunity Trial of the CXCR1\/2 Inhibitor Reparixin in Operable HER-2-Negative Breast Cancer","volume":"22","author":"Goldstein","year":"2020","journal-title":"Breast Cancer Res."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1021\/acsnano.1c09318","article-title":"Localized Degradation of Neutrophil Extracellular Traps by Photoregulated Enzyme Delivery for Cancer Immunotherapy and Metastasis Suppression","volume":"16","author":"Chen","year":"2022","journal-title":"ACS Nano"},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Al Qutami, F., AlHalabi, W., Vijayakumar, A., Rawat, S.S., Mossa, A.H., Jayakumar, M.N., Samreen, B., and Hachim, M.Y. (2024). Characterizing the Inflammatory Profile of Neutrophil-Rich Triple-Negative Breast Cancer. Cancers, 16.","DOI":"10.3390\/cancers16040747"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/adbi.202400140","article-title":"Breast Cancer Immune Landscape: Interplay Between Systemic and Local Immunity","volume":"8","author":"Gerashchenko","year":"2024","journal-title":"Adv. Biol."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Timaxian, C., Vogel, C.F.A., Orcel, C., Vetter, D., Durochat, C., Chinal, C., NGuyen, P., Aknin, M.-L., Mercier-Nom\u00e9, F., and Davy, M. (2021). Pivotal Role for Cxcr2 in Regulating Tumor-Associated Neutrophil in Breast Cancer. Cancers, 13.","DOI":"10.3390\/cancers13112584"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2217\/imt-2016-0118","article-title":"Modulation of Cancer-Specific Immune Responses by Amino Acid Degrading Enzymes","volume":"9","author":"Timosenko","year":"2017","journal-title":"Immunotherapy"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"903","DOI":"10.20892\/j.issn.2095-3941.2024.0012","article-title":"Neutrophils in the Era of Single-Cell RNA Sequencing: Functions and Targeted Therapies in Cancer","volume":"20","author":"Qin","year":"2024","journal-title":"Cancer Biol. Med."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"117474","DOI":"10.1016\/j.biopha.2024.117474","article-title":"CTC-Neutrophil Interaction: A Key Driver and Therapeutic Target of Cancer Metastasis","volume":"180","author":"Hu","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Lin, J., He, X.-L., Zhang, W.-W., and Mo, C.-F. (2025). Metabolic Reprogramming of Tumor-Associated Neutrophils in Tumor Treatment and Therapeutic Resistance. Front. Cell Dev. Biol., 13.","DOI":"10.3389\/fcell.2025.1584987"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1159\/000504087","article-title":"Expression and Function of a Disintegrin and Metalloproteinases in Cancer-Associated Fibroblasts of Colorectal Cancer","volume":"101","author":"Mochizuki","year":"2020","journal-title":"Digestion"},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Yanai, H., Yoshikawa, K., Ishida, M., Tsuta, K., Sekimoto, M., and Sugie, T. (2021). Presence of Myxoid Stromal Change and Fibrotic Focus in Pathological Examination Are Prognostic Factors of Triple-Negative Breast Cancer: Results from a Retrospective Single-Center Study. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0245725"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1158\/2159-8290.CD-12-0348","article-title":"Desmoplasia: A Response or a Niche?","volume":"2","author":"DeClerck","year":"2012","journal-title":"Cancer Discov."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"4364","DOI":"10.1021\/acssensors.4c00585","article-title":"Assessing Breast Cancer through Tumor Microenvironment Mapping of Collagen and Other Biomolecule Spectral Fingerprints\u2014A Review","volume":"9","author":"Chohan","year":"2024","journal-title":"ACS Sens."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/bcr287","article-title":"The Complexities of Breast Cancer Desmoplasia","volume":"3","author":"Walker","year":"2001","journal-title":"Breast Cancer Res."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ccell.2019.01.007","article-title":"Integrin Signaling in Cancer: Mechanotransduction, Stemness, Epithelial Plasticity, and Therapeutic Resistance","volume":"35","author":"Cooper","year":"2019","journal-title":"Cancer Cell"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1186\/s12967-025-06306-8","article-title":"Mechanical Forces in the Tumor Microenvironment: Roles, Pathways, and Therapeutic Approaches","volume":"23","author":"Zhang","year":"2025","journal-title":"J. Transl. Med."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"e2402757","DOI":"10.1002\/advs.202402757","article-title":"Personalized Vascularized Models of Breast Cancer Desmoplasia Reveal Biomechanical Determinants of Drug Delivery to the Tumor","volume":"11","author":"Offeddu","year":"2024","journal-title":"Adv. Sci."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"e70039","DOI":"10.1002\/jex2.70039","article-title":"CD147 Mediates the Metabolic Reprogramming of Cancer Associated Fibroblasts Induced by EVs Released by Differentiating Cancer Stem Cells","volume":"4","author":"Colella","year":"2025","journal-title":"J. Extracell. Biol."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Nyalali, A.M.K., Leonard, A.U., Xu, Y., Li, H., Zhou, J., Zhang, X., Rugambwa, T.K., Shi, X., and Li, F. (2023). CD147: An Integral and Potential Molecule to Abrogate Hallmarks of Cancer. Front. Oncol., 13.","DOI":"10.3389\/fonc.2023.1238051"},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Li, F., Wang, J., Yan, Y.-Q., Bai, C.-Z., and Guo, J.-Q. (2023). CD147 Promotes Breast Cancer Migration and Invasion by Inducing Epithelial-Mesenchymal Transition via the MAPK\/ERK Signaling Pathway. BMC Cancer, 23.","DOI":"10.1186\/s12885-023-11724-2"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.critrevonc.2015.09.008","article-title":"Paracrine Tumor Signaling Induces Transdifferentiation of Surrounding Fibroblasts","volume":"97","author":"Heneberg","year":"2016","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"8","DOI":"10.14445\/23939117\/IJMS-V4I6P102","article-title":"Histological Categorization of Stromal Desmoplasia in Breast Cancer and Its Diagnostic and Prognostic Utility","volume":"4","author":"Shadan","year":"2017","journal-title":"Int. J. Med. Sci."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/nrc.2016.73","article-title":"The Biology and Function of Fibroblasts in Cancer","volume":"16","author":"Kalluri","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/01.MP.0000051582.75890.2D","article-title":"Breast Cancer Stromal Myxoid Changes Are Associated with Tumor Invasion and Metastasis: A Central Role for Hyaluronan","volume":"16","author":"Wernicke","year":"2003","journal-title":"Mod. Pathol."},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Nearchou, I.P., Ueno, H., Kajiwara, Y., Lillard, K., Mochizuki, S., Takeuchi, K., Harrison, D.J., and Caie, P.D. (2021). Automated Detection and Classification of Desmoplastic Reaction at the Colorectal Tumour Front Using Deep Learning. Cancers, 13.","DOI":"10.3390\/cancers13071615"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1097\/PAS.0000000000001272","article-title":"A Multicenter Study of the Prognostic Value of Desmoplastic Reaction Categorization in Stage II Colorectal Cancer","volume":"43","author":"Ueno","year":"2019","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1097\/GOX.0b013e31829c4597","article-title":"Keloids and Hypertrophic Scars","volume":"1","author":"Huang","year":"2013","journal-title":"Plast. Reconstr. Surg. Glob. Open"},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Zhai, Q., Fan, J., Lin, Q., Liu, X., Li, J., Hong, R., and Wang, S. (2019). Tumor Stromal Type Is Associated with Stromal PD-L1 Expression and Predicts Outcomes in Breast Cancer. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0223325"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s41573-018-0004-1","article-title":"Turning Foes to Friends: Targeting Cancer-Associated Fibroblasts","volume":"18","author":"Chen","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"30962","DOI":"10.1074\/jbc.M114.594044","article-title":"The Cytokine IL-6 Reactivates Breast Stromal Fibroblasts through Transcription Factor STAT3-Dependent Up-Regulation of the RNA-Binding Protein AUF1","volume":"289","author":"Hendrayani","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"101721","DOI":"10.1016\/j.tranon.2023.101721","article-title":"Activated Breast Stromal Fibroblasts Exhibit Myoepithelial and Mammary Stem Cells Features","volume":"35","author":"Aboussekhra","year":"2023","journal-title":"Transl. Oncol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"188356","DOI":"10.1016\/j.bbcan.2020.188356","article-title":"Fibrosis and Cancer: A Strained Relationship","volume":"1873","author":"Piersma","year":"2020","journal-title":"Biochim. Et Biophys. Acta (BBA)\u2014Rev. Cancer"},{"key":"ref_118","first-page":"60","article-title":"The Type of Collagen Cross-Link Determines the Reversibility of Experimental Skin Fibrosis","volume":"1740","author":"Attema","year":"2005","journal-title":"Biochim. Et Biophys. Acta (BBA)\u2014Mol. Basis Dis."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1039\/c5ib00040h","article-title":"Human Breast Cancer Invasion and Aggression Correlates with ECM Stiffening and Immune Cell Infiltration","volume":"7","author":"Acerbi","year":"2015","journal-title":"Integr. Biol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"214430","DOI":"10.1016\/j.bioadv.2025.214430","article-title":"COL4A2 Drives ECM Remodeling and Stiffness Increasing to Promote Breast Cancer Metastasis via YAP Signaling Pathway in DECM Induced Models","volume":"177","author":"Peng","year":"2025","journal-title":"Biomater. Adv."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1038\/ncomms3516","article-title":"Angiotensin Inhibition Enhances Drug Delivery and Potentiates Chemotherapy by Decompressing Tumour Blood Vessels","volume":"4","author":"Chauhan","year":"2013","journal-title":"Nat. Commun."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1158\/2159-8290.CD-24-0002","article-title":"The Interplay between Extracellular Matrix Remodeling and Cancer Therapeutics","volume":"14","author":"Prakash","year":"2024","journal-title":"Cancer Discov."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"280","DOI":"10.7150\/ijbs.121356","article-title":"Mechanical Microenvironment in Tumor Immune Evasion: Bidirectional Regulation Between Matrix Stiffness and Immune Cells and Its Therapeutic Implications","volume":"22","author":"Ai","year":"2026","journal-title":"Int. J. Biol. Sci."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41419-024-06697-4","article-title":"Modulating Extracellular Matrix Stiffness: A Strategic Approach to Boost Cancer Immunotherapy","volume":"15","author":"Mai","year":"2024","journal-title":"Cell Death Dis."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/nrm2597","article-title":"Mechanotransduction Gone Awry","volume":"10","author":"Jaalouk","year":"2009","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1038\/s41388-023-02715-5","article-title":"SOX9 Drives KRAS-Induced Lung Adenocarcinoma Progression and Suppresses Anti-Tumor Immunity","volume":"42","author":"Zhong","year":"2023","journal-title":"Oncogene"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"e006401","DOI":"10.1136\/jitc-2022-006401","article-title":"Barriers to Immune Cell Infiltration in Tumors","volume":"11","author":"Melssen","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Feng, X., Cao, F., Wu, X., Xie, W., Wang, P., and Jiang, H. (2024). Targeting Extracellular Matrix Stiffness for Cancer Therapy. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1467602"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/s41577-022-00761-w","article-title":"Tuning Immunity through Tissue Mechanotransduction","volume":"23","author":"Du","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1158\/2159-8290.CD-24-1712","article-title":"The Immunomechanical Checkpoint PYK2 Governs Monocyte-to-Macrophage Differentiation in Pancreatic Cancer","volume":"15","author":"Xie","year":"2025","journal-title":"Cancer Discov."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"114319","DOI":"10.1016\/j.addr.2022.114319","article-title":"Targeting the Tumor Biophysical Microenvironment to Reduce Resistance to Immunotherapy","volume":"186","author":"Zhang","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"68954","DOI":"10.18632\/oncotarget.12135","article-title":"Association between Tumor-Stroma Ratio and Prognosis in Solid Tumor Patients: A Systematic Review and Meta-Analysis","volume":"7","author":"Wu","year":"2016","journal-title":"Oncotarget"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"104327","DOI":"10.1016\/j.ebiom.2022.104327","article-title":"A Systematic Review and Meta-Analysis of Intraday Effects of Ambient Air Pollution and Temperature on Cardiorespiratory Morbidities: First Few Hours of Exposure Matters to Life","volume":"86","author":"Wu","year":"2022","journal-title":"EBioMedicine"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1016\/S0140-6736(16)00561-4","article-title":"Atezolizumab in Patients with Locally Advanced and Metastatic Urothelial Carcinoma Who Have Progressed Following Treatment with Platinum-Based Chemotherapy: A Single-Arm, Multicentre, Phase 2 Trial","volume":"387","author":"Rosenberg","year":"2016","journal-title":"Lancet"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.coi.2014.01.004","article-title":"New Insights into Cancer Immunoediting and Its Three Component Phases\u2014Elimination, Equilibrium and Escape","volume":"27","author":"Mittal","year":"2014","journal-title":"Curr. Opin. Immunol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of Cancer: The Next Generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nature12213","article-title":"Mutational Heterogeneity in Cancer and the Search for New Cancer-Associated Genes","volume":"499","author":"Lawrence","year":"2013","journal-title":"Nature"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1200\/JCO.2011.41.0902","article-title":"Prognostic and Predictive Value of Tumor-Infiltrating Lymphocytes in a Phase III Randomized Adjuvant Breast Cancer Trial in Node-Positive Breast Cancer Comparing the Addition of Docetaxel to Doxorubicin with Doxorubicin-Based Chemotherapy: BIG 02-98","volume":"31","author":"Loi","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41571-021-00565-2","article-title":"Treatment Landscape of Triple-Negative Breast Cancer\u2014Expanded Options, Evolving Needs","volume":"19","author":"Bianchini","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41523-022-00468-0","article-title":"Triple Negative Breast Cancer: Pitfalls and Progress","volume":"8","author":"Zagami","year":"2022","journal-title":"npj Breast Cancer"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1200\/JCO.20.02923","article-title":"Pembrolizumab in Patients with Metastatic Breast Cancer with High Tumor Mutational Burden: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study","volume":"39","author":"Alva","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"ref_142","doi-asserted-by":"crossref","unstructured":"Dieci, M.V., Miglietta, F., and Guarneri, V. (2021). Immune Infiltrates in Breast Cancer: Recent Updates and Clinical Implications. Cells, 10.","DOI":"10.3390\/cells10020223"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"101915","DOI":"10.1016\/j.xcrm.2024.101915","article-title":"Dual Ferroptosis Induction in N2-TANs and TNBC Cells via FTH1 Targeting: A Therapeutic Strategy for Triple-Negative Breast Cancer","volume":"6","author":"Liu","year":"2025","journal-title":"Cell Rep. Med."},{"key":"ref_144","first-page":"1178223420906428","article-title":"Clinicopathological, Treatment and Event-Free Survival Characteristics in a Moroccan Population of Triple-Negative Breast Cancer","volume":"14","author":"Mouh","year":"2020","journal-title":"Breast Cancer"},{"key":"ref_145","first-page":"e42389","article-title":"Histopathological Patterns and Outcomes of Triple-Positive Versus Triple-Negative Breast Cancer: A Retrospective Study at a Tertiary Cancer Center","volume":"15","author":"Kadi","year":"2023","journal-title":"Cureus"},{"key":"ref_146","first-page":"3911","article-title":"Survival of Triple Negative versus Triple Positive Breast Cancers: Comparison and Contrast","volume":"17","author":"Negi","year":"2016","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_147","first-page":"511","article-title":"Update on Triple-Negative Breast Cancer: Prognosis Management Strategies","volume":"4","author":"Brouckaert","year":"2012","journal-title":"Int. J. Womens Health"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.3889\/oamjms.2019.808","article-title":"Comparison of Clinico-Pathological Presentations of Triple-Negative versus Triple-Positive and HER2 Iraqi Breast Cancer Patients","volume":"7","author":"Alwan","year":"2019","journal-title":"Open Access Maced. J. Med. Sci."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.cell.2020.10.036","article-title":"Proteogenomic Landscape of Breast Cancer Tumorigenesis and Targeted Therapy","volume":"183","author":"Krug","year":"2020","journal-title":"Cell"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"5621441","DOI":"10.1155\/2022\/5621441","article-title":"Prognosis of Tumor Microenvironment in Luminal B-Type Breast Cancer","volume":"2022","author":"Lv","year":"2022","journal-title":"Dis. Markers"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"eaar3593","DOI":"10.1126\/science.aar3593","article-title":"Pan-Tumor Genomic Biomarkers for PD-1 Checkpoint Blockade\u2013Based Immunotherapy","volume":"362","author":"Cristescu","year":"2018","journal-title":"Science"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1159\/000492580","article-title":"Mismatch Repair Deficiency Drives Durable Complete Remission by Targeting Programmed Death Receptor 1 in a Metastatic Luminal Breast Cancer Patient","volume":"14","author":"Fremd","year":"2019","journal-title":"Breast Care"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"100607","DOI":"10.1016\/j.modpat.2024.100607","article-title":"The Conflicting Prognostic Role of the Stroma\u2013Tumor Ratio in Breast Cancer Molecular Subtypes","volume":"37","author":"Ghannam","year":"2024","journal-title":"Mod. Pathol."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/s41573-019-0054-z","article-title":"Neutrophils as Emerging Therapeutic Targets","volume":"19","author":"Sperandio","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.1158\/0008-5472.CAN-18-3825","article-title":"IL26, a Noncanonical Mediator of DNA Inflammatory Stimulation, Promotes TNBC Engraftment and Progression in Association with Neutrophils","volume":"80","author":"Trotter","year":"2020","journal-title":"Cancer Res."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1007\/s12282-022-01369-7","article-title":"The potential role of nicotine in breast cancer initiation, development, angiogenesis, invasion, metastasis, and resistance to therapy","volume":"29","author":"Khodabandeh","year":"2022","journal-title":"Breast Cancer"},{"key":"ref_157","doi-asserted-by":"crossref","unstructured":"Munk\u00e1csy, G., Santarpia, L., and Gy\u0151rffy, B. (2023). Therapeutic Potential of Tumor Metabolic Reprogramming in Triple-Negative Breast Cancer. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24086945"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"eadf6493","DOI":"10.1126\/science.adf6493","article-title":"Deterministic Reprogramming of Neutrophils within Tumors","volume":"383","author":"Ng","year":"2024","journal-title":"Science"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"e44831","DOI":"10.1097\/MD.0000000000044831","article-title":"Neutrophils and Cancer Immunotherapy: Potential Mechanisms and Challenges in Breast Cancer\u2014A Narrative Review","volume":"104","author":"Obeagu","year":"2025","journal-title":"Medicine"},{"key":"ref_160","doi-asserted-by":"crossref","unstructured":"Ayoub, N.M., Jaradat, S.K., Al-Shami, K.M., and Alkhalifa, A.E. (2022). Targeting Angiogenesis in Breast Cancer: Current Evidence and Future Perspectives of Novel Anti-Angiogenic Approaches. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.838133"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"7837","DOI":"10.1039\/D4TB00894D","article-title":"Matrix-Degrading Soft-Nanoplatform with Enhanced Tissue Penetration for Amplifying Photodynamic Therapeutic Efficacy of Breast Cancer","volume":"12","author":"Lu","year":"2024","journal-title":"J. Mater. Chem. B"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.7150\/thno.90627","article-title":"Cancer-Associated Fibroblast Spatial Heterogeneity and EMILIN1expression in the Tumor Microenvironment Modulate TGF-\u03b2 Activity and CD8+ T-Cell Infiltration in Breast Cancer","volume":"14","author":"Honda","year":"2024","journal-title":"Theranostics"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"145006","DOI":"10.1016\/j.ijbiomac.2025.145006","article-title":"Decoding Tumors from Fibroblast Activation Protein: A Review of the Latest Diagnostic and Therapeutic Prospects","volume":"318","author":"Wang","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_164","first-page":"62","article-title":"Breaking Boundaries: Chronic Diseases and the Frontiers of Immune Microenvironments","volume":"1","author":"Li","year":"2025","journal-title":"Med. Res."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/s41571-023-00846-y","article-title":"Myeloid-Derived Suppressor Cells in Cancer and Cancer Therapy","volume":"21","author":"Lasser","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12943-020-01234-1","article-title":"Regulatory T Cells in Tumor Microenvironment: New Mechanisms, Potential Therapeutic Strategies and Future Prospects","volume":"19","author":"Li","year":"2020","journal-title":"Mol. Cancer"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.7150\/thno.51777","article-title":"Metabolic Regulatory Crosstalk between Tumor Microenvironment and Tumor-Associated Macrophages","volume":"11","author":"Chen","year":"2021","journal-title":"Theranostics"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13045-021-01103-4","article-title":"Spatial Architecture of the Immune Microenvironment Orchestrates Tumor Immunity and Therapeutic Response","volume":"14","author":"Fu","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.21037\/tlcr-21-572","article-title":"Tumor Immune Microenvironment in Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer before and after Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Treatment: A Narrative Review","volume":"10","author":"Liu","year":"2021","journal-title":"Transl. Lung Cancer Res."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"9753","DOI":"10.3390\/cimb45120609","article-title":"Metabolic Interplay in the Tumor Microenvironment: Implications for Immune Function and Anticancer Response","volume":"45","author":"Youssef","year":"2023","journal-title":"Curr. Issues Mol. Biol."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s00109-024-02452-6","article-title":"Tumor-Derived Extracellular Vesicle Proteins as New Biomarkers and Targets in Precision Oncology","volume":"102","author":"Liao","year":"2024","journal-title":"J. Mol. Med."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/s41401-020-0400-z","article-title":"Engineering Nanomedicines through Boosting Immunogenic Cell Death for Improved Cancer Immunotherapy","volume":"41","author":"Gao","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2019.12.005","article-title":"Exosome-Mediated SiRNA Delivery to Suppress Postoperative Breast Cancer Metastasis","volume":"318","author":"Zhao","year":"2020","journal-title":"J. Control. Release"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"1705581","DOI":"10.1002\/adma.201705581","article-title":"Nanocage-Therapeutics Prevailing Phagocytosis and Immunogenic Cell Death Awakens Immunity against Cancer","volume":"30","author":"Lee","year":"2018","journal-title":"Adv. Mater."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jconrel.2014.05.037","article-title":"Non-Viral Nanocarriers for SiRNA Delivery in Breast Cancer","volume":"190","author":"Zhang","year":"2014","journal-title":"J. Control. Release"},{"key":"ref_176","doi-asserted-by":"crossref","unstructured":"Almutairi, S., Kalloush, H.M., Manoon, N.A., and Bardaweel, S.K. (2023). Matrix Metalloproteinases Inhibitors in Cancer Treatment: An Updated Review (2013\u20132023). Molecules, 28.","DOI":"10.3390\/molecules28145567"},{"key":"ref_177","doi-asserted-by":"crossref","unstructured":"Mustafa, S., Koran, S., and AlOmair, L. (2022). Insights Into the Role of Matrix Metalloproteinases in Cancer and Its Various Therapeutic Aspects: A Review. Front. Mol. Biosci., 9.","DOI":"10.3389\/fmolb.2022.896099"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1158\/1535-7163.MCT-17-0646","article-title":"Matrix Metalloproteinase Inhibitors in Cancer Therapy: Turning Past Failures Into Future Successes","volume":"17","author":"Winer","year":"2018","journal-title":"Mol. Cancer Ther."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"1700867","DOI":"10.1002\/advs.201700867","article-title":"Drug-Bearing Supramolecular MMP Inhibitor Nanofibers for Inhibition of Metastasis and Growth of Liver Cancer","volume":"5","author":"Ji","year":"2018","journal-title":"Adv. Sci."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"15431","DOI":"10.1073\/pnas.1204600109","article-title":"Molecular Mechanism of Pancreatic Tumor Metastasis Inhibition by GdC 82 (OH) 22 and Its Implication for de Novo Design of Nanomedicine","volume":"109","author":"Kang","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41392-019-0054-9","article-title":"Potent Delivery of an MMP Inhibitor to the Tumor Microenvironment with Thermosensitive Liposomes for the Suppression of Metastasis and Angiogenesis","volume":"4","author":"Lyu","year":"2019","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.2217\/nnm-2019-0298","article-title":"Hampering Brain Tumor Proliferation and Migration Using Peptide Nanofiber:Si PLK1\/MMP2 Complexes","volume":"14","author":"Mazza","year":"2019","journal-title":"Nanomedicine"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1080\/10717544.2019.1698674","article-title":"A Cationic Polymeric Prodrug with Chemotherapeutic Self-Sensibilization Co-Delivering MMP-9 ShRNA Plasmid for a Combined Therapy to Nasopharyngeal Carcinoma","volume":"26","author":"Liu","year":"2019","journal-title":"Drug Deliv."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.ccell.2023.03.008","article-title":"Neutrophil Extracellular Traps Formed during Chemotherapy Confer Treatment Resistance via TGF-\u03b2 Activation","volume":"41","author":"Mousset","year":"2023","journal-title":"Cancer Cell"},{"key":"ref_185","doi-asserted-by":"crossref","unstructured":"Chen, Y., Chen, K., Xiao, X., Nie, Y., Qu, S., Gong, C., Su, F., and Song, E. (2016). Pretreatment Neutrophil-to-Lymphocyte Ratio Is Correlated with Response to Neoadjuvant Chemotherapy as an Independent Prognostic Indicator in Breast Cancer Patients: A Retrospective Study. BMC Cancer, 16.","DOI":"10.1186\/s12885-016-2352-8"},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/s41540-025-00549-3","article-title":"Single-Cell Transcriptomic Profiling of Immune Landscape in Triple-Negative Breast Cancer during Neoadjuvant Chemotherapy","volume":"11","author":"Patysheva","year":"2025","journal-title":"npj Syst. Biol. Appl."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1186\/s12943-024-02176-8","article-title":"PD-1\/PD-L1 Immune Checkpoint Blockade in Breast Cancer: Research Insights and Sensitization Strategies","volume":"23","author":"Jin","year":"2024","journal-title":"Mol. Cancer"},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1200\/JCO.2015.64.8931","article-title":"Pembrolizumab in Patients with Advanced Triple-Negative Breast Cancer: Phase Ib KEYNOTE-012 Study","volume":"34","author":"Nanda","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S1470-2045(20)30754-3","article-title":"Pembrolizumab versus Investigator-Choice Chemotherapy for Metastatic Triple-Negative Breast Cancer (KEYNOTE-119): A Randomised, Open-Label, Phase 3 Trial","volume":"22","author":"Winer","year":"2021","journal-title":"Lancet Oncol."},{"key":"ref_190","unstructured":"National Cancer Institute (NCI) (2026, January 13). Drugs Approved for Breast Cancer, Available online: https:\/\/www.cancer.gov\/about-cancer\/treatment\/drugs\/breast."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1056\/NEJMoa1809615","article-title":"Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer","volume":"379","author":"Schmid","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1056\/NEJMoa2202809","article-title":"Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer","volume":"387","author":"Cortes","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/S0140-6736(20)32531-9","article-title":"Pembrolizumab plus Chemotherapy versus Placebo plus Chemotherapy for Previously Untreated Locally Recurrent Inoperable or Metastatic Triple-Negative Breast Cancer (KEYNOTE-355): A Randomised, Placebo-Controlled, Double-Blind, Phase 3 Clinical Trial","volume":"396","author":"Cortes","year":"2020","journal-title":"Lancet"},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1038\/s41591-025-03630-w","article-title":"Sacituzumab Tirumotecan in Previously Treated Metastatic Triple-Negative Breast Cancer: A Randomized Phase 3 Trial","volume":"31","author":"Yin","year":"2025","journal-title":"Nat. Med."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1056\/NEJMoa2105215","article-title":"Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer","volume":"384","author":"Tutt","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1007\/s12282-022-01390-w","article-title":"Efficacy and Safety of Talazoparib in Japanese Patients with Germline BRCA-Mutated Locally Advanced or Metastatic Breast Cancer: Results of the Phase 1 Dose-Expansion Study","volume":"29","author":"Kotani","year":"2022","journal-title":"Breast Cancer"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/3\/404\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T05:11:12Z","timestamp":1769749872000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/3\/404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,27]]},"references-count":196,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["cancers18030404"],"URL":"https:\/\/doi.org\/10.3390\/cancers18030404","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,27]]}}}